Moody’s revises DexKo view to negative

Moody’s Investors Service said it revised the outlook for DexKo Global, Inc. to negative from under review.

“The negative outlook reflects Moody’s view that DexKo’s leverage could be sustained at elevated levels through 2021 should the company’s earnings remain pressured or the company undertakes debt-funded acquisitions that are not accretive,” said the agency in a press release.

Moody’s also confirmed the company’s B2 and B2-PD rating as well as its B-1 first-lien secured rating and Caa1 second-lien rating.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.